Demant AS (OCSE:DEMANT) Debt-to-Equity : 1.64 (As of Dec. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Demant AS Debt-to-Equity?

Demant AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr1,090 Mil. Demant AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was kr14,591 Mil. Demant AS's Total Stockholders Equity for the quarter that ended in Dec. 2024 was kr9,564 Mil. Demant AS's debt to equity for the quarter that ended in Dec. 2024 was 1.64.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Demant AS's Debt-to-Equity or its related term are showing as below:

OCSE:DEMANT' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.76 Med: 1.2 Max: 1.76
Current: 1.64

During the past 13 years, the highest Debt-to-Equity Ratio of Demant AS was 1.76. The lowest was 0.76. And the median was 1.20.

OCSE:DEMANT's Debt-to-Equity is ranked worse than
92.85% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs OCSE:DEMANT: 1.64

Demant AS Debt-to-Equity Historical Data

The historical data trend for Demant AS's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS Debt-to-Equity Chart

Demant AS Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

1.09

1.42

1.76

1.56

1.64

Demant AS Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															1.76	1.60	1.56	1.68	1.64

Competitive Comparison of Demant AS's Debt-to-Equity

For the Medical Devices subindustry, Demant AS's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Demant AS's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Demant AS's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Demant AS Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Demant AS's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1090	+	14591)	/	9564
	=	1.64

Demant AS's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1090	+	14591)	/	9564
	=	1.64

Demant AS (OCSE:DEMANT) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Demant AS Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Demant AS's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Demant AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OCSE:DEMANT) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

WILYY:USA WILLF:USA DEMANc:UK 0RGT:UK WDH:Germany DEMA:Austria

Address

Kongebakken 9, Smorum, DNK, 2765

Website

https://www.demant.com

Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.

Demant AS Headlines

No Headlines